Enanta Pharmaceuticals (ENTA) Enterprise Value Growth (5y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.31% |
| Dec 31, 2025 | 13.61% |
| Sep 30, 2025 | 13.35% |
| Jun 30, 2025 | 11.22% |
| Mar 31, 2025 | 11.45% |
| Dec 31, 2024 | 10.33% |
| Sep 30, 2024 | 5.84% |
| Jun 30, 2024 | 9.98% |
| Mar 31, 2024 | 4.10% |
| Dec 31, 2023 | 0.50% |
| Sep 30, 2023 | 22.67% |
| Jun 30, 2023 | -7.19% |
| Mar 31, 2023 | 3.93% |
| Dec 31, 2022 | 0.55% |
| Sep 30, 2022 | -2.19% |
| Jun 30, 2022 | -5.70% |
| Mar 31, 2022 | -9.81% |
| Dec 31, 2021 | -4.35% |
| Sep 30, 2021 | -3.04% |
| Jun 30, 2021 | -3.29% |
| Mar 31, 2021 | -11.27% |
| Dec 31, 2020 | -16.51% |
| Sep 30, 2020 | -21.66% |
| Jun 30, 2020 | -19.15% |
| Mar 31, 2020 | -16.51% |
| Dec 31, 2019 | -29.15% |
| Sep 30, 2019 | -29.92% |
| Jun 30, 2019 | -32.34% |
| Mar 31, 2019 | -31.32% |
| Dec 31, 2018 | -30.35% |
| Sep 30, 2018 | -24.92% |
| Jun 30, 2018 | -23.64% |
| Mar 31, 2018 | -18.66% |
| Dec 31, 2017 | -60.44% |
| Sep 30, 2017 | -38.58% |
| Jun 30, 2017 | -117.32% |
| Mar 31, 2017 | -53.35% |